REMS: FDA’s Application of Statutory Factors in Determining When a REMS Is Necessary Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
April 4, 2019
February 28, 2020
decb6a17-0d69-46dd-aca8-c4de8c5d15cd
Related Documents
Considerations in Demonstrating Interchangeability With a Reference Product Guidance for Industry
Guidance DocumentMay 14, 2019Center for Drug Evaluation and Research
Scientific Considerations in Demonstrating Biosimilarity to a Reference Product
Guidance DocumentApril 28, 2015Center for Drug Evaluation and Research
FDA’s Application of Statutory Factors in Determining When a REMS Is Necessary
Guidance DocumentApril 4, 2019Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox